Effect of Helicobacter pylori treatment on platelet count in children with ?acute ITP

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N68

Enrollment

Registered

2018-02-18

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Thrombocytopenic Purpura. Idiopathic thrombocytopenic purpura

Interventions

Intervention 1: Intervention group: In this group patients are treated with IVIG, 1 gram and Prednizolon, 2 miligram ?in combination with 3 drug Helicobacter pylori treatment including Clarithromycin

Eligibility

Sex/Gender

All

Age

2 Years to 15 Years

Inclusion criteria

Inclusion criteria: Being at the age of 2-15 years Children with ?acute ITP

Exclusion criteria

Exclusion criteria: Autoimmune disorders, AIDS and Hepatitis Patients with thrombocytopenia caused by medication and other causes Consumption Proton pump Inhibitor and H2 blocker drugs during last month Intolerance to eradication treatments for Helicobacter pylori infection

Design outcomes

Primary

Measure	Time frame
Platelet. Timepoint: At the end of the first week, the first month and the second month and the third month and the sixth month. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Aziz Eghbali

Arak University of Medical Sciences

Eghbali@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026